Tag: Duty of Care
NEW Policy brief – Time to Legislate: Realising access to medicines through States’ obligation to protect the human right to health
Rosalind Turkie -
The Pharmaceutical Accountability Foundation released its new brief today on legislative measures that States can take to realise access to medicines for all. The focus is on the States' obligations under international human rights law to protect the right to health (and access to medicines) from outside interference, for...
After Netherlands and Israel, now Italy: Leadiant fined for excessive price
FtV Projectcoordinator -
Bergeijk, June 2, 2022
The Italian Competition Authority (ICA) decided on 31 May that pharmaceutical company Leadiant has charged the Italian National Health Service excessive prices for the life-saving medicine Chenodeoxycholic acid (CDCA), and issued a fine of €3.5million.
“We believe that pharmaceutical companies have a duty of care to make...
Find the original (Dutch) article here.
Gerard Schouw responded on April 21 to the column by Marcel Levi, who two weeks earlier called for people to stop wasting money on excessively priced medicines. Schouw blames Levi for a flawed analysis and claims to refute this with figures: 'The share...
Licensed under Creative Commons (CC BY-NC-SA 4.0), The Pharmaceutical Accountability Foundation 2022